Diabetes : intravitreous ranibizumab for proliferative diabetic retinopathy

Jonathan M. Gibson*, Samantha McGinnigle

*Corresponding author for this work

Research output: Contribution to journalLetter, comment/opinion or interviewpeer-review


The Diabetic Retinopathy Clinical Research Network has published the 2-year results of a 5-year study comparing intravitreous ranibizumab with panretinal laser photocoagulation in patients with proliferative diabetic retinopathy. The results suggest that intravitreous ranibizumab will become a valuable treatment option, although its exact role remains to be defined.
Original languageEnglish
Pages (from-to)130-131
Number of pages2
JournalNature Reviews Endocrinology
Issue number3
Publication statusPublished - 22 Jan 2016

Bibliographical note



  • diabetes complications
  • drug therapy
  • eye diseases


Dive into the research topics of 'Diabetes : intravitreous ranibizumab for proliferative diabetic retinopathy'. Together they form a unique fingerprint.

Cite this